夜尿症に対するUbretidの使用経験
スポンサーリンク
概要
- 論文の詳細を見る
Nocturnal enuresis is a common disease, but is difficult one to treat. So far many different kinds of therapy have been attempted without satisfactory results. This means that there is no definite way of treatment for this particular disease because of the fact that the cause of the disease is very complicated deriving from many causal factors. Administration of "Ubretid" was attempted in 13 patients with functional nocturnal enuresis. The result was satisfactory with cure in 5 cases (38.4%), markedly effective in 2 (15.3 %), effective in 2 (15.3 %), ineffective in 2 (15.3 %) and unknown in 2 (15.3 %). No noticeable side effect was encountered. It is thought that "Ubretid" is one of preferable new drugs for nocturnal enuresis.
- 泌尿器科紀要刊行会の論文
泌尿器科紀要刊行会 | 論文
- MVAC療法後の転移性尿路上皮癌に対するGemcitabine, Docetaxel, Carboplatin併用化学療法の検討
- Grade 3 Ta-1表在性膀胱癌に対する膀胱温存治療
- 腹腔鏡下に摘出した後腹膜神経線維腫の1例
- 移植腎生検による腎内動脈瘤破裂の1例
- Modified M-VAC療法後に残存腫瘍切除を施行した進行尿路上皮癌患者の治療成績